ミシガン州における潰瘍性大腸炎の臨床試験
ミシガン州内の拠点で、潰瘍性大腸炎に関する17件の研究が参加者を募集しています。
ミシガン州内の都市
公式研究テキスト（英語）
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
- Huron Gastro, Ypsilanti
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT06598943A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483073LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Clinical Research Institute of Michigan, LLC, Clinton Township
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Huron Gastroenterology Associates, P.C., Ypsilanti
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan - Site Number: 8400060, Wyoming
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07185009Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
- University of Michigan, Ann Arbor
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/11更新 · NCT07501078Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287), Ypsilanti
被験者募集中第3相
全年齢 · 全性別 · 2026/09/09更新 · NCT06651281A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Michigan Center of Medical Research, Farmington Hills
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan - Site Number: 8400060, Wyoming
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital of Michigan, Detroit
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/03更新 · NCT06100289Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
- University of Micigan, Ann Arbor
被験者募集中
18歳以上 · 全性別 · 2026/07/23更新 · NCT07456566A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- William Beaumont Hospital/Corewell Health - East, Royal Oak
- William Beaumont Hospitals Reference Laboratory, Royal Oak
被験者募集中第2相
12歳〜17歳 · 全性別 · 2026/07/08更新 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Hospital of Michigan, Detroit
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400012, Wyoming
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/04/23更新 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Ypsilanti
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。